Publications by authors named "Thomas Denize"

Claim this Profile
T
Tumor-Intrinsic and Microenvironmental Determinants of Impaired Antitumor Immunity in Chromophobe Renal Cell Carcinoma.
Chris Labaki, Eddy Saad, Katrine N Madsen, Charbel Hobeika, Kevin Bi, Thomas Denize

J Clin Oncol· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tumor and immune reprogramming during immunotherapy in advanced renal cell carcinoma.
Kevin Bi, Meng Xiao He, Ziad Bakouny, Abhay Kanodia, Sara Napolitano, Thomas Denize

Cancer Cell· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Presence of Tertiary Lymphoid Structures and Exhausted Tissue-Resident T Cells Determines Clinical Response to PD-1 Blockade in Renal Cell Carcinoma.
Miya B Hugaboom, Lena V Wirth, Kelly Street, Neil Ruthen, Opeyemi A Jegede, Thomas Denize

Cancer Discov· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reversible downregulation of HLA class I in adenoid cystic carcinoma.
Annie Li, Bianca L Gonda, Elizabeth M Codd, Adam von Paternos, Dawn R Mitchell, Thomas Denize

J Immunother Cancer· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multinucleated tumor cells and micropapillary morphology appear to be predictors of poor prognosis in renal cell carcinoma with papillary and oncocytic features.
Ting Zhao, Thomas Denize, Hanzhang Wang, Adam S Fisch, Shulin Wu

Hum Pathol· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Generation and Characterization of Ex Vivo Expanded Tumor-infiltrating Lymphocytes From Renal Cell Carcinoma Tumors for Adoptive Cell Therapy.
David J Einstein, Brian Halbert, Thomas Denize, Sayed Matar, Destiny J West

J Immunother· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A pathology foundation model for cancer diagnosis and prognosis prediction.
Xiyue Wang, Junhan Zhao, Eliana Marostica, Wei Yuan, Jietian Jin, Thomas Denize

Nature· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Successive next-generation sequencing strategy for optimal fusion gene detection in non-small-cell lung cancer in clinical practice.
Simon Garinet, Audrey Lupo, Thomas Denize, Romain Loyaux, Sarah Timsit

Pathology· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PD-1 Expression on Intratumoral Regulatory T Cells Is Associated with Lack of Benefit from Anti-PD-1 Therapy in Metastatic Clear-Cell Renal Cell Carcinoma Patients.
Thomas Denize, Opeyemi A Jegede, Sayed Matar, Nourhan El Ahmar, Destiny J West

Clin Cancer Res· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Concordance of ASCL1, NEUROD1 and POU2F3 transcription factor-based subtype assignment in paired tumour samples from small cell lung carcinoma.
Thomas Denize, Catherine B Meador, Anna B Rider, Maria L Ganci, Jaimie L Barth

Histopathology· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cutaneous angiosarcoma of the scalp in a pediatric patient with xeroderma pigmentosum.
Valeria S Oliver-García, Kevin J Moore, Thomas Denize, Mai P Hoang, Victor A Neel

JAAD Case Rep· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synchronous occurrence of neuroblastic tumour and exocrine carcinoma of the pancreas in a child.
Thomas Denize, Sabine Irtan, Marie-Dominique Tabone, Aurore Coulomb, Sarra Gharbi

Pathology· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intravascular Lymphoma as a Cause of Recurrent Strokes - Case Report and Review of the Literature.
Charlie Weige Zhao, Tracey H Fan, Thomas Denize, Alba Coraini, Andrew Kraft

Neurohospitalist· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
K
KDM6A epigenetically regulates subtype plasticity in small cell lung cancer.
Leslie Duplaquet, Yixiang Li, Matthew A Booker, Yingtian Xie, Sarah Naomi Olsen, Thomas Denize

Nat Cell Biol· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
"
"Normal" Is Not Normal: The Role of the Immune Microenvironment of Adjacent Non-Neoplastic Tissue in Dictating the Biology of Early-Stage NSCLC.
Thomas Denize, Mari Mino-Kenudson

J Thorac Oncol· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Spatially aware deep learning reveals tumor heterogeneity patterns that encode distinct kidney cancer states.
Jackson Nyman, Thomas Denize, Ziad Bakouny, Chris Labaki, Breanna M Titchen

Cell Rep Med· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Circulating and Intratumoral Immune Determinants of Response to Atezolizumab plus Bevacizumab in Patients with Variant Histology or Sarcomatoid Renal Cell Carcinoma.
Renee Maria Saliby, Talal El Zarif, Ziad Bakouny, Valisha Shah, Wanling Xie, Thomas Denize

Cancer Immunol Res· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Acquired brachial cutaneous dyschromatosis.
Emily Everdell, Thomas Denize, Hensin Tsao

JAAD Case Rep· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II study of nivolumab and salvage nivolumab/ipilimumab in treatment-naïve patients with advanced non-clear cell renal cell carcinoma (HCRN GU16-260-Cohort B).
Michael B Atkins, Opeyemi A Jegede, Naomi B Haas, David F McDermott, Mehmet A Bilen, Thomas Denize

J Immunother Cancer· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Spatially aware deep learning reveals tumor heterogeneity patterns that encode distinct kidney cancer states.
Jackson Nyman, Thomas Denize, Ziad Bakouny, Chris Labaki, Breanna M Titchen

bioRxiv· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Epigenomic charting and functional annotation of risk loci in renal cell carcinoma.
Amin H Nassar, Sarah Abou Alaiwi, Sylvan C Baca, Elio Adib, Rosario I Corona, Thomas Denize

Nat Commun· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II Study of Nivolumab and Salvage Nivolumab/Ipilimumab in Treatment-Naive Patients With Advanced Clear Cell Renal Cell Carcinoma (HCRN GU16-260-Cohort A).
Michael B Atkins, Opeyemi A Jegede, Naomi B Haas, David F McDermott, Mehmet A Bilen, Thomas Denize

J Clin Oncol· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transcriptomic Correlates of Tumor Cell PD-L1 Expression and Response to Nivolumab Monotherapy in Metastatic Clear Cell Renal Cell Carcinoma.
Thomas Denize, Yue Hou, Jean-Christophe Pignon, Emily Walton, Destiny J West

Clin Cancer Res· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Regulation of neuroendocrine plasticity by the RNA-binding protein ZFP36L1.
Hsiao-Yun Chen, Yavuz T Durmaz, Yixiang Li, Amin H Sabet, Amir Vajdi, Thomas Denize

Nat Commun· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sensitivity of mutant kidney cancers to HIF2 inhibitors does not require an intact p53 pathway.
Laura A Stransky, Sean M Vigeant, Bofu Huang, Destiny West, Thomas Denize

Proc Natl Acad Sci U S A· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis